These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 23840128)

  • 1. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
    World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Cao JH; Zhou J; Zhang XL; Ding X; Long QY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis.
    Liu Z; Gao F; Yang G; Singh S; Lu M; Zhang T; Zhong Z; Zhang F; Tang R
    Tumour Biol; 2014 Aug; 35(8):7407-13. PubMed ID: 24777334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.
    Yan S; Xu D; Sun B
    Dig Dis Sci; 2013 Jul; 58(7):2107-13. PubMed ID: 23361576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
    Wang X; Hu Y; Ren M; Lu X; Lu G; He S
    Korean J Radiol; 2016; 17(1):93-102. PubMed ID: 26798221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma.
    Kong QF; Jiao JB; Chen QQ; Li L; Wang DG; Lv B
    Tumour Biol; 2014 Mar; 35(3):2655-9. PubMed ID: 24197985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
    Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
    Lan T; Chang L; Mn R; Wu L; Yuan YF
    Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C; Cheng G; Liao M; Huang J
    World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
    Dong W; Zhang T; Wang ZG; Liu H
    World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma.
    Jiang G; Xu X; Ren S; Wang L
    Tumour Biol; 2014 Apr; 35(4):3405-8. PubMed ID: 24277379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
    AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
    Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
    Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.